Teladoc Health, Inc.
Teladoc Health, Inc. is classed by the SEC under Services-Offices & Clinics of Doctors of Medicine (industry code 8011), based in New York, NY. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $2.5 billion and a loss of $200 million (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8011, Services-Offices & Clinics of Doctors of Medicine); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 5.2 out of ten, 9 of 9 metrics filed: past 5.2 out of ten, present 5.1 out of ten, future 5.3 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 8.9 out of ten. No warning events in its filings since 2017. 89th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 3.0 out of ten. +18.3% a year over 6 filed years; profitable in 0 of 6. 30th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 4.0 out of ten. Share count grew 3.0% a year. 0% of cash flow returned. Insiders: 37 sales, 1 purchases. 40th percentile among 6 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 6.2 out of ten. ROE -14%: lost 14¢ per shareholder dollar. Leverage 52%: owes 52¢ per asset dollar. 62nd percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 5.7 out of ten. top 44% of 9 in its family; net margin -7.9%. 56th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 2.6 out of ten. bottom 26% of 5 in its family for leadership; chief executive since 2024. 26th percentile among 5 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 6.5 out of ten. top 35% of 9 in its family for room to expand. 65th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 3.9 out of ten. bottom 39% of 8 in its family for growth drivers. 39th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 6.4 out of ten. top 36% of 6 in its family for expectations against reality. 64th percentile among 6 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-26 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-07-30 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-07-29 (on EDGAR). Newest filing: Form SCHEDULE 13G, 2026-10-08. Filings on record since 2009. Read from EDGAR 2026-10-12.
Where the revenue comes from
Product and service lines in fiscal 2025: Access Fees Revenue 83%, Other 17%. By geography: United States 82%, Outside the United States 18%. As tagged in its annual report (Form 10-K, filed 2026-02-26).
Who runs it
Divita, Charles III (CHIEF EXECUTIVE OFFICER); Bliss, Kelly (President, U.S. Group Health); Nueno, Carlos (President, International); Rodrigues, Fernando M. (President of BetterHelp); Grasher, Michael F (Chief Financial Officer); Murthy, Mala (CHIEF FINANCIAL OFFICER); Catapano, Joseph Ronald (Chief Accounting Officer); Vandervoort, Adam C (CHIEF LEGAL OFFICER, SECRETARY); Anquillare, Mark V (director); Fenwick, Sandra L (director); and 8 more. 18 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-05.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.